Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2007-02-20
2007-02-20
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S184000, C435S189000, C435S190000, C435S191000, C424S268100, C424S269100, C424S272100, C423S405000, C514S152000
Reexamination Certificate
active
09124485
ABSTRACT:
The present invention relates generally to a method for the prophylaxis and treatment of parasitic infections in animals and birds. More particularly, the present invention contemplates a method for the prophylaxis and treatment ofPlasmodiuminfection in mammals and the prophylaxis and treatment of disease conditions caused or exacerbated byPlasmodium. Even more particularly, the present invention is directed to a method for the prophylaxis and treatment of malaria including ameliorating the clinical effects of malaria and agents useful for same.
REFERENCES:
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 5814666 (1998-09-01), Green et al.
patent: 6153186 (2000-11-01), Stamler et al.
Seguin et al., Induction of nitric oxide synthase protects against malaria in mice exposed to irradiatedPlasmodium bergheiinfected mosquitoes, Journal of Experimental Medicine 180(1):353-358 (1994).
Liew et al., A possible novel pathway of regulation by murine T helper type 2 cells of a T helper type 1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages, Eur J immunol 21(10): 2489-2494 (1991).
Thurring et al., Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from native and Leishmania major infected mice, Eur J Immunol 25: 3229-3234 (1995).
Gibaldi, What is nitric oxide and why are so many people studying it, Journal of Clinical Pharmacology, 33(6): 488-496 (1993).
Losert et al. Experiences with severe P. falciparum malaria in the intensive care unit., Intensive Care Medicine, Feb. 2000, 26(2): 195-201 (Abstract).
Manual of Clinical Microbiology Murray et al. eds., American Society of Microbiology (1999), p. 1355, New York.
Cooke et al. Parasitology Today 2000 vol. 16, p. 416.
Newbold et al. Intl. J. Parasitology 1999, vol. 29, p. 927.
Anstey, N.M. et al., “Nitric Oxide in Tanzanian Children with Malaria: Inverse Relationship between Malaria Severity and Nitric Oxide Production/Nitric Oxide Synthase Type 2 Expression”; (1996)J. Exp. Med.184:557-567.
Anstey, N.M. et al., “Nitrate levels in Malaria”; (1997)Transactions of the Royal Soc. of Tropical Medicine and Hygiene91:238 (Correspondence).
Anstey, N.M. et al., “No Evidence for Increased Nitric Oxide Production in Cerebral Malaria”;Australian Society for Infectious Diseases Annual Scientific Meeting, Darwin, NT. May 21-24, 1995.
Anstey, N.M. et al. “No Evidence for Increased Synthesis of Nitric Oxide in Uncomplicated and Cerebral Malaria”;Fourth International Meeting on ‘Biology of Nitric Oxide,’ Florida, USA, Sep. 17-21, 1995, (Abstract only).
Anstey, N.M. et al. “Nitric Oxide appears Protective in Tanzanian Children with Malaria: Evidence for Increased NO Production in Subclinical Infection and Suppressed Production in Clinical and Cerebral Malaria”;The Biology of Nitric Oxide, Proceedings of the 1995 “Biology of Nitric Oxide” Conference; S. Moncada, J. Stamler, S. Gross, E.A. Higgs, eds. p. 150 and cover pages.
Anstey, N.M. et al. “Decreased Nitrate Excretion in Tanzanian Children with Uncomplicated and Cerebral Malaria”;44thAnnual Meeting of the American Society of Tropical Medicine&Hygiene, Texas, Nov. 1995, (Abstract only).
Bogdan, C., et al., “Lifelong Expression of Inducible NO Synthase is required for the Control of Leishmania Major Persisting in Clinically Cured Hosts”;Fourth International Meeting on Biology of Nitric Oxide, Florida, USA, Sep. 17-21, 1995, (Abstract only).
Clark, I.A. et al., “Nitric Oxide and Parasitic Disease”, (1996)Advances in Parasitology37:1-56.
Clark, I.A. et al. “Proposed Link Between Cytokines, Nitric Oxide and Human Cerebral Malaria”; (1991)Parasitology Today7(8):205-207.
De Caterina, R. et al., “Nitric Oxide Decreases Cytokine-induced Endothelial Activation”; (1995)J. Clin. Invest.96:60-68.
Duffy, P.E., et al. “Expression-Cloning and Immunologic Analysis of the CD36-Binding Malaria Protein, Sequestrin: Adherence Characteristics and Mechanisms of Reversal”;44thAnnual Meeting of the American Society of Tropical Medicine&Hygiene, Texas, Nov. 1995, (Abstract only).
Kremsner, P.G. et al., “High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid paraitological and clinical cure inPlasmodium falciparummalaria”; (1996)Transactions of the Royal Soc. of Tropical Medicine and Hygiene90:44-47.
Moncada, S. et al. “The L-Arginine-Nitric Oxide Pathway” (1993)The New England Journal of MedicineDec. 30, 1993, pp. 2002-2012.
Ockenhouse, C.F. et al., “Human Vascular Endothelial Cell Adhesion Receptors forPlasmodium falciparum-infected Erythrocytes: Roles for Endotheial Leukocyte Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1”; (1992)The Journal of Experimental Medicine176:1183-1189.
Proudfoot, L. et al., “LeishmaniaGlycoconjugates Synergize with Interferon-Gamma for the Production of Nitric Oxide”;Fourth International Meeting on ‘Biology of Nitric Oxide,’ Florida, USA Sep. 17-21, 1995, (Abstract only).
Rockett, K.A. et al., “Effect of Nitric Oxide on Neuronal NMDA Channels has Implications for Human Cerebral Malaria”;44thAnnual Meeting of the American Society of Tropical Medicine Hygiene, Texas, Nov. 1995, (Abstract only).
Schofield, L. et al., “Glycosylphosphatidylinositol Toxin ofPlasmodiumUp-Regulates Intercellular Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and E-Selectin Expression in Vascular Endothelial Cells and Increases Leukocyte and Parasite Cytoadherence Via Tyrosine Kinase-Dependent Signal Transduction”; (1996)The Journal of Immunology156:1886-1896.
Stamler, J.S. et al., “Nitric Oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin”; (1992)Proc.Natl.Acad. Sci. USA89:7674-7677.
Xiao, L. et al. “Cytokine Production by Endothelial Cell After Stimulation withPlasmodiuam falciparumBlood Stage Antigens” (Abstract only);44thAnnual Meeting of the American Society of Tropical Medicine&Hygiene, Texas, Nov. 1995, (Abstract only).
Weinberg, J.B. et al. “Human Mononuclear Phagocyte Inducible Nitric Oxide Synthase (iNOS): Analysis of iNOS mRNA, iNOS Protein, Biopterin, and Nitric Oxide Production by Blood Monocytes and Peritoneal Macrophages”; (1995)Blood86(3):1184-1195.
Yanez, D. et al. “Lymphocyte Subpopulations that Function in the Pathogenesis of Murine Cerebral Malaria”;44thAnnual Meeting of the American Society of Tropical Medicine&Hygiene, Texas, Nov. 1995, (Abstract only).
“World Malaria Situation”;Weekly Epidemiological RecordNo. 3, Jan. 19, 1996.
Anstey Nicholas Mark
Granger Donald L.
Weinberg Joseph Brice
Cheu Jacob
Duke University
Greenlee Winner and Sullivan P.C.
Le Long V.
Menzies School of Health Research
LandOfFree
Method of prophylaxis and treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of prophylaxis and treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prophylaxis and treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3867094